Annual Meeting Media Resource Center


  • Media registration opens: March 3
  • Housing deadline: April 23
  • Embargoed presscast for media: May 14
  • 2014 ASCO Annual Meeting: May 30 - June 3



ASCO's Media Headquarters is where you can go to apply for media credentials, register to attend an upcoming meeting, and access embargoed meeting information.

2014 Annual Meeting On-Site Media Registration and Housing Reservation Instructions

2014 Annual Meeting Frequently Asked Questions

Please refer to the 2014 Annual Meeting Media Policies for eligibility information. For further questions about how to navigate the Media Headquarters site, please contact


New Therapies Harness Power of the Immune System Against Cancer
CHICAGO – New research on innovative immunotherapies for advanced or high-risk melanoma and cervical cancer were presented today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO).  These treatments – used alone or in combination – fight cancer by activating and amplifying the body’s immune response to the disease. See the full release here.

Major Advances in Breast, Prostate and Colorectal Cancer Treatment Featured at ASCO’s Annual Meeting
CHICAGO – Findings from four phase III clinical trials in breast, prostate, and colorectal cancers were released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). The studies were presented in ASCO’s Plenary session, which features the meeting’s most important clinical cancer research with the greatest potential to impact patient care. See the full release here.

Studies Reveal Potential New Targeted Therapies for Common, Hard-to-Treat Cancers
CHICAGO – Positive results from four clinical trials of investigational targeted drugs for advanced ovarian, lung, and thyroid cancers, and chronic lymphocytic leukemia were highlighted today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). Findings from the mid- and late-stage trials suggest new ways to slow disease progression and improve survival for patients who experience relapses or resistance to available treatments. See the full release here.

Studies Reveal New Strategies to Improve Quality of Life for Patients, Survivors and Caregivers
CHICAGO – Key studies released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) identify new strategies for easing the short- and long-term effects of cancer therapy and improving the quality of life of patients with cancer, as well as their caregivers. See the full release here.

Research in Several Cancers Reveals Promising Treatment Strategies, New Insights on Screening, and Obesity-Cancer Link
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today highlighted results from five major studies to be presented at ASCO’s 50th Annual Meeting, May 30-June 3, 2014, in Chicago. The research found that hormone therapy can be safely delayed following prostate cancer relapse in some men; that implementation of recent U.S. lung cancer screening guidelines would substantially increase early-stage diagnoses, as well as overall health care costs; and that two new targeted drugs offer promise in several hard-to-treat cancers. Another study offers new insight on obesity’s relation to breast cancer mortality in younger women. See the full release here.

2014 ASCO Annual Meeting Press Program to Highlight Major Advances in Cancer Research
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today announced the studies to be featured in the 2014 ASCO Annual Meeting press program. The press program will highlight important new advances in several areas of cancer research, including immunotherapy, patient care and quality of life, and targeted therapies. See the full release here.




Information About the On-Site Press Facilities (including location and hours)


Login to webex to watch the press briefings LIVE at ASCO

Please note: You will not be able to submit questions during the Q&A portion of the live press briefing, but you will be able to listen in. The Q&A will not available in the recording.

View Press Briefing Recordings and Leadership Video Commentary


NEW THIS YEAR! If you are registered to attend the meeting as media and would like to include your Twitter handle on your meeting badge, click here.

2014 ASCO Annual Meeting Tweeters

#ASCO14 Tweetup


Cancer.Net: ASCO’s award-winning patient website, provides comprehensive, oncologist-approved information on more than 120 cancer types, together with expert information on cancer treatments, managing side effects and coping with a cancer diagnosis. When the site first launched in 2002, there were detailed sections on 22 different types of cancer. Now, Cancer.Net continues to lead the way in content, design, and interactivity, providing patients, their families and friends with timely and authoritative information.

CancerProgress.Net: offers a detailed, interactive timeline of advances against 17 of the most common cancers. The site also includes simple, interactive charts on cancer survival, mortality, and incidence, along with downloadable timelines, historical commentary and other reporting resources.

Visit the Virtual Press Room to view third party press releases related to the 2014 ASCO Annual Meeting


Interview Requests
Please do not send media registration requests to this email address.

Media Registration Questions

Questions About New Annual Meeting Embargo Policies
All requests must be submitted in writing.

Broadcasting Live from the Meeting
Kelly Baldwin,

General Questions About the Meeting
Wendy Stokes,
Kelly Baldwin,
Kate Blackburn,  
Alise Fisher,